Canada markets closed

Hyloris Pharmaceuticals SA (HYL.BR)

Brussels - Brussels Delayed Price. Currency in EUR
Add to watchlist
11.700.00 (0.00%)
At close: 05:37PM CEST
Show:
Income Statement
Cash Flow
Annual

Balance Sheet

All numbers in thousands
Breakdown
2022-12-31
2021-12-31
2020-12-31
2019-12-31
Assets
Current Assets
Cash
Cash And Cash Equivalents
43,457
50,012
64,399
205
Other Short Term Investments
469
528
7
-
Total Cash
43,926
50,540
64,406
205
Net Receivables
5,127
2,321
48
58
Other Current Assets
-
1,098
1,954
1
Total Current Assets
50,801
53,959
66,613
3,739
Non-current assets
Property, plant and equipment
Gross property, plant and equipment
1,185
516
335
207
Accumulated Depreciation
-125
-221
-159
-109
Net property, plant and equipment
1,060
295
176
98
Intangible Assets
3,607
2,944
2,381
2,138
Other long-term assets
1
1,714
-
-
Total non-current assets
11,063
9,485
2,569
2,245
Total Assets
61,864
63,444
69,182
5,983
Liabilities and stockholders' equity
Liabilities
Current Liabilities
Current Debt
0
11,815
409
13,130
Accounts Payable
2,302
2,622
1,595
2,866
Other Current Liabilities
-
-
1
2
Total Current Liabilities
5,772
14,978
2,132
16,149
Non-current liabilities
Long Term Debt
-
300
7,885
0
Other long-term liabilities
-
1
-
-
Total non-current liabilities
1,047
410
7,991
22
Total Liabilities
6,819
15,388
10,123
16,171
Stockholders' Equity
Common Stock
140
129
129
89
Retained Earnings
-64,246
-54,805
-43,226
-36,081
Total stockholders' equity
55,045
48,056
59,059
-10,188
Total liabilities and stockholders' equity
61,864
63,444
69,182
5,983